These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 35418255)
1. Urgent surgery versus anticoagulation for treatment of superficial vein thrombosis in patients with varicose veins. Casian D; Bzovii F; Culiuc V; Gutu E Vasa; 2022 May; 51(3):174-181. PubMed ID: 35418255 [No Abstract] [Full Text] [Related]
2. Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT). Bauersachs R; Gerlach HE; Heinken A; Hoffmann U; Langer F; Noppeney T; Pittrow D; Klotsche J; Rabe E Eur J Vasc Endovasc Surg; 2021 Aug; 62(2):241-249. PubMed ID: 34210599 [TBL] [Abstract][Full Text] [Related]
3. Determinants of Late Venous Thromboembolic Events After Acute Isolated Superficial Vein Thrombosis in Daily Practice: 12 Month Results of the INSIGHTS-SVT Study. Rabe E; Hoffmann U; Schimke A; Heinken A; Langer F; Noppeney T; Pittrow D; Klotsche J; Gerlach HE; Bauersachs R; Eur J Vasc Endovasc Surg; 2023 Nov; 66(5):697-704. PubMed ID: 37573936 [TBL] [Abstract][Full Text] [Related]
4. A systematic review and meta-analysis for the association between duration of anticoagulation therapy and the risk of venous thromboembolism in patients with lower limb superficial venous thrombosis. Lobastov K; Dubar E; Schastlivtsev I; Bargandzhiya A J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101726. PubMed ID: 38008180 [TBL] [Abstract][Full Text] [Related]
7. Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. The OPTIMEV study. Galanaud JP; Genty C; Sevestre MA; Brisot D; Lausecker M; Gillet JL; Rolland C; Righini M; Leftheriotis G; Bosson JL; Quere I; Thromb Haemost; 2011 Jan; 105(1):31-9. PubMed ID: 20886192 [TBL] [Abstract][Full Text] [Related]
8. Medical management of acute superficial vein thrombosis of the saphenous vein. Scovell SD; Ergul EA; Conrad MF J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):109-117. PubMed ID: 29097174 [TBL] [Abstract][Full Text] [Related]
9. Isolated Great Saphenous Vein Thrombus Is Associated with High Rates of Complications regardless of Management. Kudlaty E; Oriowo B; Yang MJ; Go MR; Satiani B Ann Vasc Surg; 2017 Nov; 45():154-159. PubMed ID: 28600022 [TBL] [Abstract][Full Text] [Related]
10. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies. Galanaud JP; Bosson JL; Genty C; Presles E; Cucherat M; Sevestre MA; Quere I; Decousus H; Leizorovicz A J Thromb Haemost; 2012 Jun; 10(6):1004-11. PubMed ID: 22429908 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis. Di Minno MN; Ambrosino P; Ambrosini F; Tremoli E; Di Minno G; Dentali F J Thromb Haemost; 2016 May; 14(5):964-72. PubMed ID: 26845754 [TBL] [Abstract][Full Text] [Related]
13. A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum). Cosmi B; Filippini M; Tonti D; Avruscio G; Ghirarduzzi A; Bucherini E; Camporese G; Imberti D; Palareti G; J Thromb Haemost; 2012 Jun; 10(6):1026-35. PubMed ID: 22487001 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of isolated superficial vein thrombosis in patients with active cancer. Galanaud JP; Blaise S; Sevestre MA; Terrisse H; Pernod G; Gaillard C; Genty C; Monreal M; Rabah Y; Kahn SR; Quéré I; Bosson JL; Thromb Res; 2018 Nov; 171():179-186. PubMed ID: 29789147 [TBL] [Abstract][Full Text] [Related]
15. Thromboembolic outcomes are decreased with the use of a standardized venous thromboembolism risk assessment and prophylaxis protocol for patients undergoing superficial venous procedures. Braet DJ; Loi K; Stabler C; Vemuri C; Coleman DM; Obi AT; Wakefield TW J Vasc Surg Venous Lymphat Disord; 2023 Sep; 11(5):928-937.e1. PubMed ID: 37127256 [TBL] [Abstract][Full Text] [Related]
16. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643 [TBL] [Abstract][Full Text] [Related]
17. Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study. Barco S; Pomero F; Di Minno MND; Tamborini Permunian E; Malato A; Pasca S; Barillari G; Fenoglio L; Siragusa S; Di Minno G; Ageno W; Dentali F J Thromb Haemost; 2017 Nov; 15(11):2176-2183. PubMed ID: 28871623 [TBL] [Abstract][Full Text] [Related]
18. Venous Thromboembolism Prophylaxis and Thrombotic Risk Stratification in the Varicose Veins Surgery-Prospective Observational Study. Wołkowski K; Wołkowski M; Urbanek T J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33297575 [TBL] [Abstract][Full Text] [Related]